Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price fell 1% during trading on Tuesday . The company traded as low as GBX 10 ($0.13) and last traded at GBX 10 ($0.13). 560,198 shares traded hands during mid-day trading, an increase of 315% from the average session volume of 134,951 shares. The stock had previously closed at GBX 10.10 ($0.14).
Tissue Regenix Group Trading Down 11.6%
The company has a market cap of £6.36 million, a price-to-earnings ratio of -467.54 and a beta of 1.61. The company’s fifty day moving average price is GBX 26.52 and its two-hundred day moving average price is GBX 30.70. The company has a quick ratio of 2.36, a current ratio of 4.03 and a debt-to-equity ratio of 31.16.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Featured Stories
- Five stocks we like better than Tissue Regenix Group
- How to Use the MarketBeat Dividend Calculator
- 3 REITs to Watch as Rate Cuts Ignite a Real Estate Super Cycle
- What Are the U.K. Market Holidays? How to Invest and Trade
- 2 Defense Stocks Riding 2025’s Massive Momentum Wave
- What Are Dividend Champions? How to Invest in the Champions
- TrumpRx Brings Pfizer Into the Green—Is It a Buy?
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
